The role of surgery in the management of isolated metastases to the pancreas

The Lancet Oncology

Volumn 10, Issue 3, 2009, Pages 287-293

  Reddy, Sushanth ^a   Wolfgang, Christopher L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; DOXORUBICIN; IMATINIB;

CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; GASTROINTESTINAL STROMAL TUMOR; HUMAN; KIDNEY CARCINOMA; MELANOMA; NEUROENDOCRINE TUMOR; PANCREAS CANCER; PANCREAS METASTASECTOMY; PANCREAS METASTASIS; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SARCOMA; SURGICAL TECHNIQUE; SURVIVAL RATE; COLORECTAL TUMOR; KIDNEY TUMOR; METASTASIS; PANCREAS TUMOR; PATHOLOGY;

CARCINOMA, RENAL CELL; COLORECTAL NEOPLASMS; HUMANS; KIDNEY NEOPLASMS; PANCREATIC NEOPLASMS; PATIENT SELECTION; SARCOMA;

EID: 62849103162     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70065-8     Document Type: Review

References (59)

1. Foster J.H. Survival after liver resection for secondary tumors. Am J Surg 135 (1978) 389-394
2. McCormack P.M., Burt M.E., Bains M.S., Martini N., Rusch V.W., and Ginsberg R.J. Lung resection for colorectal metastases. 10-year results. Arch Surg 127 (1992) 1403-1406
3. Lee W.S., Yun H.R., Yun S.H., et al. Treatment outcomes of hepatic and pulmonary metastases from colorectal carcinoma. J Gastroenterol Hepatol 23 (2008) 367-372
4. Reddy S., Edil B.H., Cameron J.L., et al. Pancreatic resection of isolated metastases from non-pancreatic primary cancers. Ann Surg Oncol 15 (2008) 3199-3206
5. Varker K.A., Muscarella P., Wall K., Ellison C., and Bloomston M. Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection. World J Surg Oncol 5 (2007) 145
6. Zerbi A., Ortolano E., Balzano G., et al. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?. Ann Surg Oncol 15 (2008) 1161-1168
7. Bahra M., Jacob D., Langrehr J.M., et al. Metastatic lesions to the pancreas. When is resection reasonable?. Chirurg 79 (2008) 241-248
8. Hiotis S.P., Klimstra D.S., Conlon K.C., and Brennan M.F. Results after pancreatic resection for metastatic lesions. Ann Surg Oncol 9 (2002) 675-679
9. Matsutani T., Sasajima K., Miyamoto M., et al. Resection of pancreatic metastasis from renal cell carcinoma and an early gastric cancer. J Nippon Med Sch 75 (2008) 41-45
10. Dumitrascu T., Dima S., Popescu C., et al. An unusual indication for central pancreatectomy-late pancreatic metastasis of ocular malignant melanoma. Chirurgia (Bucur) 103 (2008) 479-485
11. Aimoto T., Uchida E., Yamahatsu K., Yoshida H., Hiroi M., and Tajiri T. Surgical treatment for isolated multiple pancreatic metastases from renal cell carcinoma: report of a case. J Nippon Med Sch 75 (2008) 221-224
12. Palmowski M., Hacke N., Satzl S., et al. Metastasis to the pancreas: characterization by morphology and contrast enhancement features on CT and MRI. Pancreatology 8 (2008) 199-203
13. Wente M.N., Kleeff J., Esposito I., et al. Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature. Pancreas 30 (2005) 218-222
14. Law C.H., Wei A.C., Hanna S.S., et al. Pancreatic resection for metastatic renal cell carcinoma: presentation, treatment, and outcome. Ann Surg Oncol 10 (2003) 922-926
15. Le Borgne J., Partensky C., Glemain P., Dupas B., and de Kerviller B. Pancreaticoduodenectomy for metastatic ampullary and pancreatic tumors. Hepatogastroenterology 47 (2000) 540-544
16. Eidt S., Jergas M., Schmidt R., and Siedek M. Metastasis to the pancreas-an indication for pancreatic resection?. Langenbecks Arch Surg 392 (2007) 539-542
17. Ghavamian R., Klein K.A., Stephens D.H., et al. Renal cell carcinoma metastatic to the pancreas: clinical and radiological features. Mayo Clin Proc 75 (2000) 581-585
18. Crippa S., Angelini C., Mussi C., et al. Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg 30 (2006) 1536-1542
19. Sohn T.A., Yeo C.J., Cameron J.L., Nakeeb A., and Lillemoe K.D. Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg 5 (2001) 346-351
20. Faure J.P., Tuech J.J., Richer J.P., Pessaux P., Arnaud J.P., and Carretier M. Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival. J Urol 165 (2001) 20-22
21. Sperti C., Pasquali C., Liessi G., Pinciroli L., Decet G., and Pedrazzoli S. Pancreatic resection for metastatic tumors to the pancreas. J Surg Oncol 83 (2003) 161-166
22. Butturini G., Bassi C., Falconi M., et al. Surgical treatment of pancreatic metastases from renal cell carcinomas. Dig Surg 15 (1998) 241-246
23. Kassabian A., Stein J., Jabbour N., et al. Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology 56 (2000) 211-215
24. Kohler K., Haroske G., and Ludwig K. Management of pancreatic metastases from renal cell carcinoma report of five cases. Zentralbl Chir 131 (2006) 425-428
25. Winter J.M., Cameron J.L., Campbell K.A., et al. 1423 pancreaticoduodnectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10 (2006) 1199-1210
26. Dindo D., Demartines N., and Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004) 205-213
27. Zisman A., Pantuck A.J., Chao D., et al. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. J Urol 166 (2001) 54-58
28. Fourquier P., Regnard J.F., Rea S., Levi J.F., and Levasseur P. Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothorac Surg 11 (1997) 17-21
29. Jung E.J., Lee H.J., Kwak C., Ku J.H., and Moon K.C. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma. Urology 73 (2009) 137-141
30. Minervini A., Di Cristofano C., Gacci M., et al. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. J Urol 180 (2008) 1284-1289
31. Crispen P.L., Sheinin Y., Roth T.J., et al. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res 14 (2008) 5150-5157
32. Zhang H., Ye D., Yao X., et al. Role of KIT expression in the prognosis of clear cell renal cell carcinomas in Chinese patients. J Cancer Res Clin Oncol 135 (2009) 249-253
33. American Joint Committee on Cancer. AJCC Cancer Staging Manual 5th edition, 231-234 (1997), Lippincott-Raven Publishers, Philadelphia, PA
34. Cerfolio R.J., Allen M.S., Deschamps C., et al. Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 57 (1994) 339-344
35. Kavolius J.P., Mastorakos D.P., Pavlovich C., Russo P., Burt M.E., and Brady M.S. Resection of metastatic renal cell carcinoma. J Clin Oncol 16 (1998) 2261-2266
36. Friedel G., Hurtgen M., Penzenstadler M., Kyriss T., and Toomes H. Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 19 (1999) 1593-1596
37. Piltz S., Meimarakis G., Wichmann M.W., Hatz R., Schildberg F.W., and Fuerst H. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73 (2002) 1082-1087
38. Pfannschmidt J., Hoffmann H., Muley T., Krysa S., Trainer C., and Dienemann H. Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74 (2002) 1653-1657
39. Murthy S.C., Kim K., Rice T.W., et al. Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?. Ann Thorac Surg 79 (2005) 996-1003
40. Pfannschmidt J., Klode J., Muley T., Dienemann H., and Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg 81 (2006) 448-454
41. Ferretti S., Fornia S., Ampollini L., et al. Lung metastasectomy in patients with renal cell cancer (RCC). A 17-year experience in Parma Hospital. Acta Biomed 78 (2007) 41-45
42. Jamison R.L., Donohue J.H., Nagorney D.M., Rosen C.B., Harmsen W.S., and Ilstrup D.M. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 132 (1997) 505-510
43. Fernandez F.G., Drebin J.A., Linehan D.C., Dehdashti F., Siegel B.A., and Strasberg S.M. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-8 fluorodeoxyglucose (FDG-PET). Ann Surg 240 (2004) 438-447
44. Choti M.A., Sitzmann J.V., Tiburi M.F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002) 759-766
45. Jarnagin W.R., Fong Y., Ky A., et al. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg 188 (1999) 33-42
46. Ollila D.W. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol 7 (2006) 919-924
47. Agrawal S., Yao T.J., and Coit D.G. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol 6 (1999) 336-344
48. Ollila D.W., Essner R., Wanek L.A., and Morton D.L. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 131 (1996) 975-979
49. Ricaniadis N., Konstadoulakis M.M., Walsh D., and Karakousis C.P. Gastrointestinal metastases from malignant melanoma. Surg Oncol 4 (1995) 105-110
50. Blanke C.D., Rankin C., Demetri G.D., et al. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 26 (2008) 626-632
51. Zalupski M., Metch B., Balcerzak S., et al. Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst 83 (1991) 926-932
52. van Geel A.N., van Coevorden F., Blankensteijn J.D., et al. Surgical treatment of pulmonary metastases from soft tissue sarcomas: a retrospective study in The Netherlands. J Surg Oncol 56 (1994) 172-177
53. van Geel A.N., Pastorino U., Jauch K.W., et al. Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 77 (1996) 675-682
54. Rehders A., Peiper M., Stoecklein N.H., et al. Hepatic metastasectomy for soft-tissue sarcomas: is it justified?. World J Surg 33 (2009) 111-117
55. Sosa J.A., Bowman H.M., Gordon T.A., et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 228 (1998) 429-438
56. Glasgow R.E., and Mulvihill S.J. Hospital volume influences outcome in patients undergoing pancreatic resection for cancer. West J Med 165 (1996) 294-300
57. McPhee J.T., Hill J.S., Whalen G.F., et al. Perioperative mortality for pancreatectomy: a national perspective. Ann Surg 246 (2007) 246-253
58. Bassi C., Butturini G., Falconi M., Sargenti M., Mantovani W., and Pederzoli P. High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg 90 (2003) 555-559
59. Gohji K., Matsumoto O., and Kamidono S. Solitary pancreatic metastasis from renal cell carcinoma. Hinyokika Kiyo 36 (1990) 677-681